Core One Labs Inc. - CEO, Joel Shacker
CEO, Joel Shacker
Source: YouTube
Market Herald logo

Subscribe

Be the first with the news that moves the market
  • Core One Labs Inc. (COOL) acquires all the outstanding share capital of Awakened Biosciences Inc. for $9.76 million
  • Core One and Awakened are psychedelics research and technology companies
  • Core One Labs has issued seven million common shares and 1.4 million share purchase warrants at a price of $1.15 per share
  • The company has also issued 140,600 common shares to certain third parties
  • Core One Labs Inc. (COOL) is up 10 per cent and is trading at $1.21 per share as of 12:23 p.m. EST

Core One Labs Inc. (COOL) has acquired all outstanding share capital of Awakened Biosciences for $9.76 million.

Core One and Awakened are psychedelics research and technology companies. Awakened’s production methods can produce psychedelic compounds at scale for reduced costs.

Core One Labs has issued seven million common shares and 1.4 million share purchase warrants at a price of $1.15 per share until February 4, 2024.

This entitles the holders to acquire an equivalent number of common shares of Core One Labs.

The company has also issued 140,600 common shares to certain third parties involved in the transaction.

The transaction was completed in connection to a share purchase agreement.

Acquiring these shares allows the expansion of Core One’s portfolio of subsidiaries specializing in psychedelic compounds, and the methods its scientists can employ.

Awakened’s novel production methods require filing three provisional patent applications for the protection of its proprietary technologies.

Joel Shacker, Core One CEO, stated,

“With the addition of Awakened to the Core One family, the company has increased expansion opportunities, furthered its psychedelic products portfolio, and secured potential for immediate revenue generation.”

Core One Labs Inc. (COOL) is up 10 per cent and is trading at $1.21 per share as of 12:23 p.m. EST.



More From The Market Herald

" Optimi Health (CSE:OPTI) acquires catalog of psychedelic and functional mushroom genetics

Optimi Health (OPTI) has acquired a catalog of psilocybin and functional mushroom strains.

" Nirvana Life Sciences Inc (CSE:NIRV) signs LOI with Innovate Phytotechnologies Inc

Nirvana Life Sciences (NIRV) has  signed a letter of intent with Innovate Phytotechnologies Inc. (INVP)
Clearmind Medicine - CEO, Adi Zuloff Shani.

" Clearmind Medicine (CSE:CMND) announces upcoming pre-IND meeting with the FDA

Clearmind (CMND) will participate in a pre-IND meeting with the FDA on May 18, 2022.
Red Light Holland - Advisor, Akwasi Owusu Bempah.

" Red Light Holland (CSE:TRIP) adds Akwasi Owusu-Bempah to Advisory Board

Red Light Holland (TRIP) has hired drug law expert Akwasi Owusu-Bempah as its newest advisor.